Found 4 matching trials
Study to Assess GW642444 in Asthma Patients
PHASE2This is a study of GW642444M, a long-acting beta 2 specific agonist. This s...
Location
GSK Investigational Site
A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients.
PHASE2This study will involve the use of a new compound, GW642444 that is being d...
Location
GSK Investigational Site
A Study To Assess The Safety And Tolerability Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
PHASE2The compound GW642444 has previously been found to be well tolerated with n...
Location
GSK Investigational Site
A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients
PHASE1This study will involve the use of a new compound, GW642444 that is being d...
Location
GSK Investigational Site